Literature DB >> 21922531

Basophils and plasmacytoid dendritic cells are potential sources for error in flow cytometric monitoring of patients receiving anti-CD22 therapies. AKA not all anti-CD22 antibodies are created equal.

Malcolm Acon-Laws1, Michael G Bayerl, Christopher Ehman, Jozef Malysz, Cinda Boyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21922531     DOI： 10.1002/ajh.22130

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  2 in total

1.  Flow Cytometric Monitoring for Residual Disease in B Lymphoblastic Leukemia Post T Cell Engaging Targeted Therapies.

Authors:  Sindhu Cherian; Maryalice Stetler-Stevenson
Journal:  Curr Protoc Cytom       Date:  2018-09-13

Review 2.  B-cell targeted therapeutics in clinical development.

Authors:  Stephan Blüml; Kathleen McKeever; Rachel Ettinger; Josef Smolen; Ronald Herbst
Journal:  Arthritis Res Ther       Date:  2013-04-04       Impact factor: 5.156
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.